Rigel Pharmaceuticals
RIGL
RIGL
107 hedge funds and large institutions have $210M invested in Rigel Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 42 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $316M → $210M (-$105M)
48% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
107
Holding in Top 10
–
Calls
$202K
Puts
$262K
Top Buyers
| 1 | +$13.7M | |
| 2 | +$4.8M | |
| 3 | +$4.08M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.76M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.55M |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$3.33M | |
| 3 | -$2.74M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.55M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$2.4M |